These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 577367)
1. Toxoplasmic chorioretinitis affecting the macula. Saari M Acta Ophthalmol (Copenh); 1977 Jun; 55(3):539-47. PubMed ID: 577367 [TBL] [Abstract][Full Text] [Related]
2. Choroidal neovascularization as a late complication of ocular toxoplasmosis. Fine SL; Owens SL; Haller JA; Knox DL; Patz A Am J Ophthalmol; 1981 Mar; 91(3):318-22. PubMed ID: 6163361 [TBL] [Abstract][Full Text] [Related]
3. [Toxoplasmic chorioretinitis: positive PCR on vitreous with negative serology for Toxoplasma gondii]. Bidgoli S; Koch P; Caspers L J Fr Ophtalmol; 2011 Jun; 34(6):384.e1-5. PubMed ID: 21492958 [TBL] [Abstract][Full Text] [Related]
4. Unilateral Acute Macular Toxoplasmic Chorioretinitis Associated with White Dot-Like Choroidal Involvement Demonstrated on Indocyanine Green Angiography. İpek ŞC; Çakar Özdal P; Kavukçu S; Saatci AO Turk J Ophthalmol; 2020 Aug; 50(4):248-251. PubMed ID: 32854470 [TBL] [Abstract][Full Text] [Related]
12. Upward extension of an atrophic tract of the retinal pigment epithelium associated with congenital macular toxoplasmosis. Khairallah M; Ladjimi A; Messaoud R; Ben Yahia S; Hmidi K Eur J Ophthalmol; 1999; 9(1):71-2. PubMed ID: 10230598 [TBL] [Abstract][Full Text] [Related]
13. Atypical spherical deposition on vitreoretinal interface associated with toxoplasmic chorioretinitis. Guagnini AP; De Potter P; Levecq L; Kozyreff A Graefes Arch Clin Exp Ophthalmol; 2007 Jan; 245(1):158-60. PubMed ID: 16612633 [TBL] [Abstract][Full Text] [Related]
14. [Efficacy of specific chemotherapy in the prevention of recurrences of toxoplasmic chorioretinitis during the 4 years following the treatment]. Timsit JC; Bloch-Michel E J Fr Ophtalmol; 1987; 10(1):15-23. PubMed ID: 3598056 [TBL] [Abstract][Full Text] [Related]
15. Intraocular inflammation associated with ocular toxoplasmosis: relationships at initial examination. Dodds EM; Holland GN; Stanford MR; Yu F; Siu WO; Shah KH; Ten Dam-van Loon N; Muccioli C; Hovakimyan A; Barisani-Asenbauer T; Am J Ophthalmol; 2008 Dec; 146(6):856-65.e2. PubMed ID: 19027421 [TBL] [Abstract][Full Text] [Related]
16. Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Bosch-Driessen LE; Berendschot TT; Ongkosuwito JV; Rothova A Ophthalmology; 2002 May; 109(5):869-78. PubMed ID: 11986090 [TBL] [Abstract][Full Text] [Related]
18. Visual function and macular architecture in patients with inactive zone 2 and 3 toxoplasmic retinochoroiditis. Azevedo MH; Moura GL; Camilo EN; Muccioli C; Arantes TE Arq Bras Oftalmol; 2015; 78(5):273-7. PubMed ID: 26466223 [TBL] [Abstract][Full Text] [Related]
19. An epidemiologic study of 100 cases of toxoplasmic uveitis: implications for diagnosis and prevention. CHODOS JB; HABEGGER-CHODOS HE Can Med Assoc J; 1963 Mar; 88(10):505-11. PubMed ID: 14020958 [TBL] [Abstract][Full Text] [Related]
20. Risk of reactivation of toxoplasmic retinitis following intraocular procedures without the use of prophylactic therapy. Heringer GC; Oueghlani E; Dell'Omo R; Curi AL; Oréfice F; Pavésio CE Br J Ophthalmol; 2014 Sep; 98(9):1218-20. PubMed ID: 24820044 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]